Summary concordance index for meta-analysis of prognosis studies with a survival outcome

Stat Med. 2021 Oct 30;40(24):5218-5236. doi: 10.1002/sim.9121. Epub 2021 Jun 30.

Abstract

In prognosis studies to evaluate association between a continuous biomarker and a survival outcome, investigators often classify subjects into two subclasses of the high- and low-expression groups and apply simple survival analysis techniques of the Kaplan-Meier method and the logrank test. The high- and low-expressions are defined according to whether or not the observation of the biomarker is higher than the cut-off value, which is heterogeneous across studies. The heterogeneous definitions of the cut-off value make it difficult to apply the standard meta-analysis techniques. We propose a method to estimate the concordance index for a survival outcome synthesizing published prognosis studies, in which the Kaplan-Meier estimates for the high- and low-expression groups are reported. We illustrate our proposed method with a real dataset for meta-analysis of prognosis studies evaluating Ki-67 in early breast cancer and evaluate its performance with a simulation study.

Keywords: Kaplan-Meier estimator; bi-variate normal model; diagnostic medicine; parametric bootstrap; summary receiver operating characteristics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Breast Neoplasms*
  • Diagnostic Tests, Routine
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Meta-Analysis as Topic
  • Prognosis
  • Survival Analysis

Substances

  • Biomarkers